OP-103 The Relationship Between Heart Failure Stage/Symptom Class and Red Blood Cell Distribution Width

2014 ◽  
Vol 113 (7) ◽  
pp. S27-S28
Author(s):  
E. Celik ◽  
S. Cay ◽  
F. Oksuz ◽  
T. Cankurt ◽  
M.A. Mendi ◽  
...  
Keyword(s):  
Heart Failure ◽  
Blood Cell ◽  
Red Blood Cell ◽  
Cell Distribution ◽  
Distribution Width ◽  
The Relationship ◽  
Red Blood Cell Distribution

Red blood cell distribution width predicts new-onset anemia in heart failure patients

2012 ◽  
Vol 160 (3) ◽  
pp. 196-200 ◽  
Author(s):  
Domingo A. Pascual-Figal ◽  
Juan C. Bonaque ◽  
Sergio Manzano-Fernández ◽  
Asunción Fernández ◽  
Iris P. Garrido ◽  
...  
Keyword(s):  
Heart Failure ◽  
Blood Cell ◽  
Red Blood Cell ◽  
Cell Distribution ◽  
Distribution Width ◽  
Heart Failure Patients ◽  
Red Blood Cell Distribution ◽  
New Onset

scholarly journals Red blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus

2017 ◽  
Vol 16 (1) ◽  
Author(s):  
Andrew Xanthopoulos ◽  
Gregory Giamouzis ◽  
Andreas Melidonis ◽  
Takeshi Kitai ◽  
Efi Paraskevopoulou ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Heart Failure ◽  
Blood Cell ◽  
Prognostic Marker ◽  
Red Blood Cell ◽  
Cell Distribution ◽  
Distribution Width ◽  
Patients With Heart Failure ◽  
Red Blood Cell Distribution

A thousand words about the link between red blood cell distribution width and heart failure

2019 ◽  
Vol 88 (1) ◽  
pp. 52-57
Author(s):  
Pawel Nowinka ◽  
Eduoard Korab-Karpinski ◽  
Przemysław Guzik
Keyword(s):  
Heart Failure ◽  
Blood Cell ◽  
Clinical Outcomes ◽  
Red Blood Cell ◽  
Strong Predictor ◽  
Nutritional Deficiencies ◽  
Cell Distribution ◽  
Distribution Width ◽  
Mortality And Morbidity ◽  
Red Blood Cell Distribution

A link between the red blood cell distribution width (RDW) and clinical outcomes in heart failure (HF) was reported for the first time in 2007. Since then, many studies have shown that an increased RDW is an independent and strong predictor of mortality and morbidity in patients with acute, decompensated or chronic HF. The evidence for such a link comes from dozens of prospective and retrospective studies in which clinical data from hundreds or even thousands of patients were examined. Although many processes such as nutritional deficiencies (e.g. iron, folate, vitamin B12), inflammation (interleukin 6, tumour necrosis factor), malnutrition, renal failure or tissue and organ hypoxia have been proposed, no clear explanation exists or is commonly accepted. This mini‑review summarises the clinical evidence on the increased RDW as a predictor of adverse clinical outcomes in HF patients, and hypothetical mechanisms that might be responsible for this interesting clinical observation.

Sign in / Sign up

Export Citation Format

Share Document